Retatrutide is primarily recommended for adults with obesity or metabolic conditions who have not achieved sufficient results with diet and exercise alone
In their attempt to delineate the relative contribution of GLP-1 versus glucagon to this effect, Hansen et al
If you find yourself struggling with side effects after increasing your dose, drop down to the dose below for another 4 weeks
(PubMed) Booth SL, Golly I, Sacheck JM, et al
Mechanistically, mazdutide is a dual agonist, activating the GLP-1 and glucagon receptors, while retatrutide is a triple agonist, adding GIP into the mix alongside GLP-1 and glucagon
Compounded hair loss formulations are supported by a growing body of retrospective data, case series, and real-world evidence